Vontobel Holding
NTLA icon

Vontobel Holding’s Intellia Therapeutics NTLA Stock Holding History

Vontobel Holding’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
20,613
+5,565
+37% +$77.9K ﹤0.01% 1186
2026
Q1 		$193K Buy
+15,048
New +$192K ﹤0.01% 1119
2022
Q2 		– Sell
-12,264
Closed -$885K – 1088
2022
Q1 		$885K Sell
12,264
-1,732
-12% -$147K 0.01% 654
2021
Q4 		$1.66M Buy
13,996
+10,296
+278% +$1.29M 0.01% 495
2021
Q3 		$496K Buy
+3,700
New +$560K ﹤0.01% 796

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Vontobel Holding's NTLA Position: Q2 2026 in Review

Vontobel Holding increased its Intellia Therapeutics (NTLA) stake by 37% in Q2 2026, buying an estimated $77.9K and bringing the position to 20,613 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Vontobel Holding first reported a position in NTLA in Q3 2021 and has held it in 5 quarters since. The position peaked at $1.66M in Q4 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Vontobel Holding held 20,613 shares of Intellia Therapeutics worth $349K as of Q2 2026.
  • Vontobel Holding bought 5,565 Intellia Therapeutics shares in Q2 2026, an estimated $77.9K.
  • Intellia Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1186 holding.
  • Vontobel Holding first reported a position in Intellia Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • Vontobel Holding's Intellia Therapeutics position peaked at $1.66M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.